Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9746 USD | -3.50% | +7.18% | -29.38% |
05-06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
04-26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.38% | 188M | |
+2.93% | 108B | |
-3.55% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Transcript : Bluebird bio, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 10